Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vascular Surgery

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    June 2016
  1. GRIMFJARD P, Erlinge D, Koul S, Lagerqvist B, et al
    Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report.
    Am Heart J. 2016;176:78-82.
    PubMed     Text format     Abstract available


  2. DE LUCA L, Capranzano P, Patti G, Parodi G, et al
    Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations.
    Am Heart J. 2016;176:44-52.
    PubMed     Text format     Abstract available


  3. VAN DER HEIJDEN LC, Kok MM, Danse PW, Schramm AR, et al
    Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial.
    Am Heart J. 2016;176:28-35.
    PubMed     Text format     Abstract available


  4. ANDERSON LL, Dai D, Miller AL, Roe MT, et al
    Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2016;176:1-9.
    PubMed     Text format     Abstract available


    April 2016
  5. GARGIULO G, Costa F, Ariotti S, Biscaglia S, et al
    Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.
    Am Heart J. 2016;174:95-102.
    PubMed     Text format     Abstract available


  6. ADAMS GL, Mustapha J, Gray W, Hargus NJ, et al
    The LIBERTY study: Design of a prospective, observational, multicenter trial to evaluate the acute and long-term clinical and economic outcomes of real-world endovascular device interventions in treating peripheral artery disease.
    Am Heart J. 2016;174:14-21.
    PubMed     Text format     Abstract available


  7. KOHL LP, Leimberger JD, Chiswell K, Jones WS, et al
    Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.
    Am Heart J. 2016;174:7-13.
    PubMed     Text format     Abstract available


  8. LIKOSKY DS, Zhang M, Paone G, Collins J, et al
    Impact of institutional culture on rates of transfusions during cardiovascular procedures: The Michigan experience.
    Am Heart J. 2016;174:1-6.
    PubMed     Text format     Abstract available


    March 2016
  9. UEDA H, Kido A, Matsuhisa S, Asawa K, et al
    Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
    Am Heart J. 2016;173:134-42.
    PubMed     Text format     Abstract available


  10. LU J, Bagai A, Buller C, Cheema A, et al
    Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program.
    Am Heart J. 2016;173:126-33.
    PubMed     Text format     Abstract available


  11. ACHARJEE S, Teo KK, Jacobs AK, Hartigan PM, et al
    Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Am Heart J. 2016;173:108-17.
    PubMed     Text format     Abstract available


  12. VAVALLE JP, van Diepen S, Clare RM, Hochman JS, et al
    Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
    Am Heart J. 2016;173:57-66.
    PubMed     Text format     Abstract available


  13. VASSALLI G, Klersy C, De Servi S, Galatius S, et al
    Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
    Am Heart J. 2016;173:1-7.
    PubMed     Text format     Abstract available


    February 2016
  14. THIELE H, Desch S, Piek JJ, Stepinska J, et al
    Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.
    Am Heart J. 2016;172:160-9.
    PubMed     Text format     Abstract available


  15. SAIKI H, Sugimoto M, Kuwata S, Kurishima C, et al
    Novel mechanisms for cerebral blood flow regulation in patients with congenital heart disease.
    Am Heart J. 2016;172:152-9.
    PubMed     Text format     Abstract available


  16. CALAIS F, Lagerqvist B, Leppert J, James SK, et al
    Thrombus aspiration in patients with large anterior myocardial infarction: A Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia trial substudy.
    Am Heart J. 2016;172:129-34.
    PubMed     Text format     Abstract available


  17. SARA JD, Lennon RJ, Gulati R, Singh M, et al
    Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis.
    Am Heart J. 2016;172:115-28.
    PubMed     Text format     Abstract available


  18. DONOVAN RJ, Ha J, Sumption KF, Dardik A, et al
    Adjunctive anticoagulation during peripheral vascular intervention.
    Am Heart J. 2016;172:106-14.
    PubMed     Text format     Abstract available


  19. LIU Y, Chen JY, Huo Y, Ge JB, et al
    Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEM
    Am Heart J. 2016;172:88-95.
    PubMed     Text format     Abstract available


  20. DIDIER R, Gaglia MA Jr, Koifman E, Kiramijyan S, et al
    Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables.
    Am Heart J. 2016;172:80-7.
    PubMed     Text format     Abstract available


  21. SEBBEN JC, Pinto Ribeiro DR, Lopes RD, de Winter R, et al
    The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2016;172:26-33.
    PubMed     Text format     Abstract available


  22. WANG TY, McCoy LA, Bhatt DL, Rao SV, et al
    Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
    Am Heart J. 2016;172:9-18.
    PubMed     Text format     Abstract available


    January 2016
  23. EYUBOGLU M
    Preoperative diagnosis and postoperative prognosis in patients undergoing coronary artery bypass graft surgery.
    Am Heart J. 2016;171:e9.
    PubMed     Text format    


  24. JONES WS, Patel MR, Tsai TT, Shetterly SM, et al
    Response to Letter to the Editor regarding "Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization".
    Am Heart J. 2016;171:e7.
    PubMed     Text format    


  25. EYUBOGLU M
    Clinical outcomes in patients with lower extremity peripheral artery disease undergoing revascularization.
    Am Heart J. 2016;171:e5.
    PubMed     Text format    


  26. HERTZBERG D, Sartipy U, Holzmann MJ
    Letter in response to "Assessing the association of diabetes mellitus with acute kidney injury after coronary artery bypass grafting" by Fu-Shan Xue et al.
    Am Heart J. 2016;171:e3.
    PubMed     Text format    


  27. BAINEY KR, Norris C, Shavadia J
    Response to: Letter to the Editor regarding the manuscript "Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Di
    Am Heart J. 2016;171:e11.
    PubMed     Text format    


  28. XUE FS, Liu GP, Li RP
    Assessing the association of diabetes mellitus with acute kidney injury after coronary artery bypass grafting.
    Am Heart J. 2016;171:e1-2.
    PubMed     Text format    


  29. KIM EK, Choi JH, Song YB, Hahn JY, et al
    A protective role of early collateral blood flow in patients with ST-segment elevation myocardial infarction.
    Am Heart J. 2016;171:56-63.
    PubMed     Text format     Abstract available


  30. WARREN J, Mehran R, Baber U, Xu K, et al
    Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI)
    Am Heart J. 2016;171:40-7.
    PubMed     Text format     Abstract available


  31. SHAH R, Rogers KC, Matin K, Askari R, et al
    An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention.
    Am Heart J. 2016;171:14-24.
    PubMed     Text format     Abstract available


  32. KOLLURI R, Plessa AL, Sanders MC, Singh NK, et al
    A randomized study of the safety and efficacy of fondaparinux versus placebo in the prevention of venous thromboembolism after coronary artery bypass graft surgery.
    Am Heart J. 2016;171:1-6.
    PubMed     Text format     Abstract available


    December 2015
  33. CHANDRASEKHAR J, Mastoris I, Baber U, Sartori S, et al
    Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
    Am Heart J. 2015;170:1234-42.
    PubMed     Text format     Abstract available


  34. BOYDEN TF, Joynt KE, McCoy L, Neely ML, et al
    Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan.
    Am Heart J. 2015;170:1227-33.
    PubMed     Text format     Abstract available


  35. IZADI AMOLI A, Bozorgi A, HajHossein Talasaz A, Salehi Omran A, et al
    Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: A randomized, placebo-controlled trial.
    Am Heart J. 2015;170:1195-201.
    PubMed     Text format     Abstract available


  36. SPENCER FA, Sekercioglu N, Prasad M, Lopes LC, et al
    Culprit vessel versus immediate complete revascularization in patients with ST-segment myocardial infarction-a systematic review.
    Am Heart J. 2015;170:1133-9.
    PubMed     Text format     Abstract available


  37. PRATI F, Romagnoli E, Limbruno U, Pawlowski T, et al
    Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.
    Am Heart J. 2015;170:1116-23.
    PubMed     Text format     Abstract available


  38. DASARI TW, Saucedo JF, Krim S, Alkhouli M, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2015;170:1086-91.
    PubMed     Text format     Abstract available


  39. KOHSAKA S, Miyata H, Ueda I, Masoudi FA, et al
    An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS).
    Am Heart J. 2015;170:1077-85.
    PubMed     Text format     Abstract available


    November 2015
  40. DUDEK D, Dziewierz A, Widimsky P, Bolognese L, et al
    Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myo
    Am Heart J. 2015;170:1025-1032.
    PubMed     Text format     Abstract available


  41. GOTBERG M, Christiansen EH, Gudmundsdottir I, Sandhall L, et al
    Instantaneous Wave-Free Ratio versus Fractional Flow Reserve guided intervention (iFR-SWEDEHEART): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial.
    Am Heart J. 2015;170:945-50.
    PubMed     Text format     Abstract available


  42. RAO SV, Zeymer U, Douglas PS, Al-Khalidi H, et al
    A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial
    Am Heart J. 2015;170:929-37.
    PubMed     Text format     Abstract available


  43. HERTZBERG D, Sartipy U, Holzmann MJ
    Type 1 and type 2 diabetes mellitus and risk of acute kidney injury after coronary artery bypass grafting.
    Am Heart J. 2015;170:895-902.
    PubMed     Text format     Abstract available


  44. CANTOR WJ, Mehta SR, Yuan F, Dzavik V, et al
    Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial.
    Am Heart J. 2015;170:880-6.
    PubMed     Text format     Abstract available


  45. COHEN MG, Matthews R, Maini B, Dixon S, et al
    Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Am Heart J. 2015;170:872-9.
    PubMed     Text format     Abstract available


  46. CHEN WR, Hu SY, Chen YD, Zhang Y, et al
    Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2015;170:845-54.
    PubMed     Text format     Abstract available


    October 2015
  47. CHHATRIWALLA AK, Venkitachalam L, Kennedy KF, Stolker JM, et al
    Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.
    Am Heart J. 2015;170:796-804.
    PubMed     Text format     Abstract available


  48. KURZ DJ, Bernheim AM, Tuller D, Zbinden R, et al
    Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: Results from the BAsel Stent Kosten-Effektivitats Trial PROspective Validation Examination randomized trial.
    Am Heart J. 2015;170:787-795.
    PubMed     Text format     Abstract available


  49. WANG TY, Henry TD, McCoy LA, Berger PB, et al
    Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.
    Am Heart J. 2015;170:706-14.
    PubMed     Text format     Abstract available


  50. NICOLAU JC, Bhatt DL, Roe MT, Lokhnygina Y, et al
    Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition t
    Am Heart J. 2015;170:683-694.
    PubMed     Text format     Abstract available


  51. ACHILLI F, Malafronte C, Cesana F, Maggiolini S, et al
    Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: Rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial.
    Am Heart J. 2015;170:652-658.
    PubMed     Text format     Abstract available


  52. ZIMMERMANN FM, De Bruyne B, Pijls NH, Desai M, et al
    Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients wi
    Am Heart J. 2015;170:619-626.
    PubMed     Text format     Abstract available


    September 2015
  53. DUPPEN N, Etnel JR, Spaans L, Takken T, et al
    Does exercise training improve cardiopulmonary fitness and daily physical activity in children and young adults with corrected tetralogy of Fallot or Fontan circulation? A randomized controlled trial.
    Am Heart J. 2015;170:606-14.
    PubMed     Text format     Abstract available


  54. KIM C, Kim BK, Lee SY, Shin DH, et al
    Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.
    Am Heart J. 2015;170:591-7.
    PubMed     Text format     Abstract available


  55. KERTAI MD, Li YJ, Ji Y, Qi W, et al
    Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery.
    Am Heart J. 2015;170:580-590.
    PubMed     Text format     Abstract available


  56. DAUBERT MA, Massaro J, Liao L, Pershad A, et al
    High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction.
    Am Heart J. 2015;170:550-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: